Platinum Industries Limited — Investor Meet, 18-02-2026: Analysts/Institutional Investor Meet/Con. Call Updates

The company delivered strong Q3 FY26 standalone revenue of ₹102.62 Cr (+31% YoY) and 9M FY26 revenue of ₹302.38 Cr (+25% YoY), primarily from CPVC demand. Q3 PAT grew 18% YoY to ₹12.93 Cr, though margins were impacted by higher initial CPVC sales.

Management projects over 40% revenue growth in FY27 and a 35% CAGR through FY29 (excluding pharma). Growth will be fueled by the Palghar facility ramp-up and the Egypt plant commissioning by Q3 FY27, which offers global market access and cost efficiencies. The company, which is net debt-free, also announced a new pharma subsidiary and is exploring Oleo derivatives, signaling a strategic focus on diversification and innovation.